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Abstract: 
Aim: The aim of the present study was to investigate the effectiveness of transforming growth factor 
(TGF)-beta 1 antisense oligodeoxynucleotides (ODN) in ameliorating deteriorated kidney function in 
rats with puromycin-induced chronic renal failure (CRF). Methods: Saline, puromycin, 
puromycin+TGF-beta 1 antisense ODN or puromycin+scrambled ODN were administered to 
unilaterally nephrectomized rats. Renal hemodynamic and excretory measurements were taken in the 
anaesthetized rats that had undergone surgical procedure. Results: It was observed that in the CRF 
rats, there was a marked reduction in the renal blood flow (RBF), glomerular filtration rate (GFR), 
severe proteinuria, and almost 6-fold increased fractional excretion of sodium (FE Na+) as compared 
to that in the control rats (all P < 0.05). It was further observed that in the CRF rats, the treatment with 
TGF-beta 1 antisense, but not scrambled ODN, markedly attenuated the reduction of RBF, GFR, and 
proteinuria and markedly prevented the increase of the FE Na+ (all P < 0.05). In addition, the renal 
hypertrophy in the CRF group (P < 0.05 vs non-renal failure control) was markedly attenuated after 
treatment with TGF-1 antisense ODN (P < 0.05). Focal segmental glomerulosclerosis was evident 
only in the untreated and scrambled ODN-treated CRF groups. An interesting observation of this study 
was that in the CRF rats, although there was marked attenuating and preventive effects of the TGF-
beta 1 antisense ODN on the deteriorated renal functions, the antisense treatment did not cause any 
marked change in the renal expression of TGF-beta 1 at the protein level. Conclusion: Collectively, 
the data obtained suggests that TGF-beta 1 antisense ODN possesses beneficial effects in puromycin-
induced chronic renal failure and that the deterioration in morphology and impaired renal function in 
this pathological state is in part dependent upon the action of TGF-beta 1 within the kidney. 
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